Show simple item record

dc.contributor.authorMilne-Ives, Madison
dc.contributor.authorRehman, N
dc.contributor.authorSharif, R
dc.contributor.authorMeinert, Edward
dc.date.accessioned2021-04-21T06:34:33Z
dc.date.issued2021-06-10
dc.identifier.issn1929-0748
dc.identifier.issn1929-0748
dc.identifier.urihttp://hdl.handle.net/10026.1/17058
dc.description.abstract

Background: Adverse drug event reporting is critical for ensuring patient safety; however, numbers of reports have been declining. There is a need for a more user-friendly reporting system and for a means of verifying reports that have been filed. Objectives: This project has two main objectives: 1) to identify the perceived benefits and barriers in the current reporting of adverse events by patients and healthcare providers and 2) to develop a distributed ledger infrastructure and user interface to collect and collate adverse event reports to create a comprehensive and interoperable database. Methods: A review of the literature will be conducted to identify the strengths and limitations of the current UK adverse event reporting system (the Yellow Card System). If insufficient information is found in this review, a survey will be created to collect data from system users. The results of these investigations will be incorporated into the development of a mobile and web app for adverse event reporting. A digital infrastructure will be built using distributed ledger technology to provide a means of linking reports with existing pharmaceutical tracking systems. Results: The key outputs of this project will be the development of a digital infrastructure including the backend distributed ledger system and the app-based user interface. Conclusions: This infrastructure is expected to improve the accuracy and efficiency of adverse event reporting systems by enabling the monitoring of specific medicines or medical devices over their life course while protecting patients’ personal health data.

dc.format.extente28616-e28616
dc.format.mediumElectronic
dc.languageen
dc.language.isoen
dc.publisherJMIR Publications
dc.rightsAttribution 4.0 International
dc.rightsAttribution 4.0 International
dc.rightsAttribution 4.0 International
dc.rightsAttribution 4.0 International
dc.rightsAttribution 4.0 International
dc.rightsAttribution 4.0 International
dc.rightsAttribution 4.0 International
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectadverse drug reaction reporting systems
dc.subjectblockchain
dc.subjectdistributed ledger technology
dc.subjectdrug-related side effects and adverse reactions
dc.subjectmobile applications
dc.titleDistributed Ledger Infrastructure to Verify adverse Event Reporting (DeLIVER): Proposal for a proof-of-concept study
dc.typejournal-article
dc.typeJournal Article
plymouth.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/34110292
plymouth.issue6
plymouth.volume10
plymouth.publication-statusPublished online
plymouth.journalJMIR Research Protocols
dc.identifier.doi10.2196/28616
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/School of Nursing and Midwifery
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
plymouth.organisational-group/Plymouth/Users by role/Researchers in ResearchFish submission
dc.publisher.placeCanada
dcterms.dateAccepted2021-04-14
dc.rights.embargodate2021-4-22
dc.identifier.eissn1929-0748
dc.rights.embargoperiodNot known
rioxxterms.versionofrecord10.2196/28616
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by/4.0/
rioxxterms.licenseref.startdate2021-06-10
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's license is described as Attribution 4.0 International

All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV